Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)

China flag China · Delayed Price · Currency is CNY
4.320
+0.030 (0.70%)
At close: Mar 10, 2026
1.65%
Market Cap 5.10B
Revenue (ttm) 1.71B
Net Income (ttm) 144.49M
Shares Out 1.19B
EPS (ttm) 0.13
PE Ratio 34.20
Forward PE n/a
Dividend 0.04 (0.93%)
Ex-Dividend Date Sep 25, 2025
Volume 13,676,920
Average Volume 14,515,230
Open 4.310
Previous Close 4.290
Day's Range 4.300 - 4.340
52-Week Range 3.770 - 5.480
Beta 0.32
RSI 43.93
Earnings Date Apr 27, 2026

About SHE:300194

Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China. It offers APIs; intermediates; and FFPs, such as anti-tumor, generic drugs, antibiotics and oral, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqing, the Peopl... [Read more]

Sector Healthcare
Founded 2004
Employees 3,392
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300194
Full Company Profile

Financial Performance

In 2024, SHE:300194's revenue was 2.39 billion, a decrease of -9.68% compared to the previous year's 2.65 billion. Earnings were 279.84 million, an increase of 20.69%.

Financial Statements

News

There is no news available yet.